These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 8691472)

  • 1. Acyl-CoA:Cholesterol O-acyltransferase (ACAT) inhibitors. 2. 2-(1,3-Dioxan-2-yl)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Astles PC; Ashton MJ; Bridge AW; Harris NV; Hart TW; Parrott DP; Porter B; Riddell D; Smith C; Williams RJ
    J Med Chem; 1996 Mar; 39(7):1423-32. PubMed ID: 8691472
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitors of acyl-CoA:cholesterol O-acyltransferase. synthesis and pharmacological activity of (+/-)-2-dodecyl-alpha-phenyl-N-(2,4,6-trimethoxyphenyl)-2H-tetrazole-5- acetamide and structurally related tetrazole amide derivatives.
    O'Brien PM; Sliskovic DR; Picard JA; Lee HT; Purchase CF; Roth BD; White AD; Anderson M; Mueller SB; Bocan T; Bousley R; Hamelehle KL; Homan R; Lee P; Krause BR; Reindel JF; Stanfield RL; Turluck D
    J Med Chem; 1996 Jun; 39(12):2354-66. PubMed ID: 8691430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibitors of acyl CoA:cholesterol acyltransferase.
    Vaccaro W; Amore C; Berger J; Burrier R; Clader J; Davis H; Domalski M; Fevig T; Salisbury B; Sher R
    J Med Chem; 1996 Apr; 39(8):1704-19. PubMed ID: 8648610
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potent inhibitors of acyl-CoA:cholesterol acyltransferase. 2. Structure-activity relationships of novel N-(2,2-dimethyl-2,3-dihydrobenzofuran-7-yl)amides.
    Kataoka K; Shiota T; Takeyasu T; Minoshima T; Watanabe K; Tanaka H; Mochizuki T; Taneda K; Ota M; Tanabe H; Yamaguchi H
    J Med Chem; 1996 Mar; 39(6):1262-70. PubMed ID: 8632433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis of novel 4,5-diphenylthiazole derivatives as potential acyl-CoA:cholesterol O-acyltransferase inhibitors.
    Romeo G; Salerno L; Milla P; Siracusa M; Cattel L; Russo F
    Pharmazie; 1999 Jan; 54(1):19-23. PubMed ID: 9987793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heterocyclic amides: inhibitors of acyl-CoA:cholesterol O-acyl transferase with hypocholesterolemic activity in several species and antiatherosclerotic activity in the rabbit.
    White AD; Purchase CF; Picard JA; Anderson MK; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Krause BR; Lee P; Stanfield RL; Reindel JF
    J Med Chem; 1996 Sep; 39(20):3908-19. PubMed ID: 8831757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Acyl-CoA:cholesterol O-acyl transferase (ACAT) inhibitors. 1. 2-(Alkylthio)-4,5-diphenyl-1H-imidazoles as potent inhibitors of ACAT.
    Harris NV; Smith C; Ashton MJ; Bridge AW; Bush RC; Coffee EC; Dron DI; Harper MF; Lythgoe DJ; Newton CG
    J Med Chem; 1992 Nov; 35(23):4384-92. PubMed ID: 1447739
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationships between lipophilicity and biological activities in a series of indoline-based anti-oxidative acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Takahashi K; Kunishiro K; Kasai M; Miike T; Kurahashi K; Shirahase H
    Arzneimittelforschung; 2008; 58(12):666-72. PubMed ID: 19202739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acyl CoA:cholesterol acyltransferase (ACAT) inhibitors: synthesis and structure-activity relationship studies of a new series of trisubstituted imidazoles.
    Higley CA; Wilde RG; Maduskuie TP; Johnson AL; Pennev P; Billheimer JT; Robinson CS; Gillies PJ; Wexler RR
    J Med Chem; 1994 Oct; 37(21):3511-22. PubMed ID: 7932580
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and structure-activity relationship studies on a novel series of naphthylidinoylureas as inhibitors of acyl-CoA:cholesterol O-acyltransferase (ACAT).
    Ohnuma S; Muraoka M; Ioriya K; Ohashi N
    Bioorg Med Chem Lett; 2004 Mar; 14(5):1309-11. PubMed ID: 14980688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypolipidemic and antioxidant activity of the novel acyl-CoA:cholesterol acyltransferase (ACAT) inhibitor KY-455 in rabbits and hamsters.
    Nakamura S; Kamiya S; Shirahase H; Kanda M; Yoshimi A; Tarumi T; Kurahashi K
    Arzneimittelforschung; 2004; 54(2):102-8. PubMed ID: 15038459
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies on acyl-CoA: cholesterol acyltransferase (ACAT) inhibitory effects and enzyme selectivity of F-1394, a pantotheic acid derivative.
    Kusunoki J; Aragane K; Yamaura T; Ohnishi H
    Jpn J Pharmacol; 1995 Mar; 67(3):195-203. PubMed ID: 7630037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-activity relationship of a series of phenylureas linked to 4-phenylimidazole. Novel potent inhibitors of acyl-CoA:cholesterol O-acyltransferase with antiatherosclerotic activity. 2.
    Kimura T; Watanabe N; Matsui M; Hayashi K; Tanaka H; Ohtsuka I; Saeki T; Kogushi M; Kabayashi H; Akasaka K
    J Med Chem; 1993 May; 36(11):1641-53. PubMed ID: 8496931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypolipidaemic properties of a potent and bioavailable alkylsulphinyl-diphenylimidazole ACAT inhibitor (RP 73163) in animals fed diets low in cholesterol.
    Riddell D; Bright CP; Burton BJ; Bush RC; Harris NV; Hele D; Moore UM; Naik K; Parrott DP; Smith C; Williams RJ
    Biochem Pharmacol; 1996 Oct; 52(8):1177-86. PubMed ID: 8937424
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Quantitative structure-activity relationship of 4,5-diphenyl-2-(substituted thio)-1H-imidazoles as the inhibitors of acyl CoA: cholesterol acyltransferase.
    Singh P; Kumar R
    Indian J Biochem Biophys; 1998 Jun; 35(3):179-83. PubMed ID: 9803668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acyl-coenzyme A:cholesterol acyltransferase inhibitors for controlling hypercholesterolemia and atherosclerosis.
    Miyazaki A; Sakai M; Sakamoto Y; Horiuchi S
    Curr Opin Investig Drugs; 2003 Sep; 4(9):1095-9. PubMed ID: 14582454
    [TBL] [Abstract][Full Text] [Related]  

  • 17. alpha-Substituted malonester amides: tools to define the relationship between ACAT inhibition and adrenal toxicity.
    Sliskovic DR; Picard JA; O'Brien PM; Liao P; Roark WH; Roth BD; Anderson MA; Mueller SB; Bocan TM; Bousley RF; Hamelehle KL; Homan R; Reindel JF; Stanfield RL; Turluck D; Krause BR
    J Med Chem; 1998 Feb; 41(5):682-90. PubMed ID: 9513596
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, synthesis, and structure--activity relationship studies for a new imidazole series of J774 macrophage specific acyl-CoA:cholesterol acyltransferase (ACAT) inhibitors.
    Maduskuie TP; Wilde RG; Billheimer JT; Cromley DA; Germain S; Gillies PJ; Higley CA; Johnson AL; Pennev P; Shimshick EJ
    J Med Chem; 1995 Mar; 38(7):1067-83. PubMed ID: 7707310
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acyl-CoA : cholesterol acyltransferase inhibitors from Magnolia obovata.
    Kwon BM; Kim MK; Lee SH; Kim JA; Lee IR; Kim YK; Bok SH
    Planta Med; 1997 Dec; 63(6):550-1. PubMed ID: 9434609
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imidazolylbenzopyrane derivatives: a new class of acyl-CoA: cholesterol acyltransferase (ACAT) inhibitors.
    Fancelli D; Chiari A; Cozzi P; Lovisolo P; Severino D; Ghiselli G
    J Enzyme Inhib; 1994; 8(3):159-72. PubMed ID: 7539485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.